Dominic C. Foo

102 Pokfulam Road
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Genetically Engineered Probiotic Nanoplatform for Ultrasound-Enhanced Colorectal Cancer Therapy via Targeted Delivery, Immune Modulation, and Anti-Angiogenesis.

Genetically Engineered Probiotic Nanoplatform for Ultrasound-Enhanced Colorectal Cancer Therapy via Targeted Delivery, Immune Modulation, and Anti-Angiogenesis.

Journal: MedComm
Published: July 05, 2025

Cancer cell SPOCD1 promotes colorectal cancer liver metastasis by activating the CXCL12/CXCR4 signaling pathway in cancer-associated fibroblasts.

Cancer cell SPOCD1 promotes colorectal cancer liver metastasis by activating the CXCL12/CXCR4 signaling pathway in cancer-associated fibroblasts.

Journal: Journal of translational medicine
Published: February 22, 2025

Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study.

Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study.

Journal: Frontiers in pharmacology
Published: June 14, 2024

Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients.

Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients.

Journal: International journal of cancer
Published: May 03, 2024

Tissue Cadherin 17 (CDH17): An Important Prognostic Determinant of Colorectal Cancer Using Digital Image Analysis.

Tissue Cadherin 17 (CDH17): An Important Prognostic Determinant of Colorectal Cancer Using Digital Image Analysis.

Journal: Cancer reports (Hoboken, N.J.)
Published: May 01, 2024

A Four-Gene Panel in Rectal Swab Samples as a Biomarker for Colorectal Cancer Screening.

A Four-Gene Panel in Rectal Swab Samples as a Biomarker for Colorectal Cancer Screening.

Journal: Cells
Published: April 26, 2024

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients.

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients.

Journal: International journal of molecular sciences
Published: March 27, 2023

High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer.

High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer.

Journal: Cells
Published: June 30, 2022

Perception from students regarding online synchronous interactive teaching in the clinical year during COVID-19 pandemic.

Perception from students regarding online synchronous interactive teaching in the clinical year during COVID-19 pandemic.

Journal: BMC medical education
Published: June 23, 2022

High Expression of a Cancer Stemness-Related Gene, Chromobox 8 (CBX8), in Normal Tissue Adjacent to the Tumor (NAT) Is Associated with Poor Prognosis of Colorectal Cancer Patients.

High Expression of a Cancer Stemness-Related Gene, Chromobox 8 (CBX8), in Normal Tissue Adjacent to the Tumor (NAT) Is Associated with Poor Prognosis of Colorectal Cancer Patients.

Journal: Cells
Published: March 21, 2022

CD26 Induces Colorectal Cancer Angiogenesis and Metastasis through CAV1/MMP1 Signaling.

CD26 Induces Colorectal Cancer Angiogenesis and Metastasis through CAV1/MMP1 Signaling.

Journal: International journal of molecular sciences
Published: December 02, 2021

MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.

MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.

Journal: BMC cancer
Published: August 24, 2021
Showing 1-12 of 31

Last Updated: 09/26/2026